Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Fr | Brain+ A/S: Brain+ A/S - Minutes of Annual General Meeting | 60 | GlobeNewswire (Europe) | Copenhagen, Denmark, 30 May 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Today at 08:00 CEST, the Annual General Meeting was held in Brain+ A/S, ("Brain+" or "the Company"). A total of 16.45 % of... ► Artikel lesen | |
28.05. | BRAIN+ A/S: Leading UK dementia care authority, Antony Hall, joins Brain+ as Strategic Advisor | 2 | Cision News | ||
BRAIN+ A/S Aktie jetzt für 0€ handeln | |||||
26.05. | BRAIN+ A/S: Brain+ signs its second UK sales agreement on Ayla with Park Homes UK Group | 1 | Cision News | ||
15.05. | BRAIN+ A/S: Brain+ A/S convenes the Annual General Meeting for 2025 | 1 | Cision News | ||
05.05. | Brain+ A/S: Brain+ selected for the NHS Dementia Innovators Programme in the UK | 182 | GlobeNewswire (Europe) | Copenhagen, Denmark, 5 May 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or "the Company") has been selected for the Dementia Innovators Programme in the United Kingdom (UK),... ► Artikel lesen | |
29.04. | BRAIN+ A/S: Brain+ publishes its Annual Report for 2024 | 3 | Cision News | ||
16.04. | Brain+ A/S: Brain+ appoints CCO Devika Wood as new CEO | 184 | GlobeNewswire (Europe) | Copenhagen, Denmark, 16 April 2025 - Brain+ A/S (Nasdaq First North: BRAINP)Brain+ A/S ("Brain+" or the "Company") announces that the Board has appointed the Company's Chief Commercial Officer (CCO)... ► Artikel lesen | |
09.04. | BRAIN+ A/S: Brain+ announces directed issue of units to convertible loan providers and guarantors | 1 | Cision News | ||
03.04. | BRAIN+ A/S: Contract signed with Copenhagen Municipality on extended and expanded access to Ayla | 2 | Cision News | ||
02.04. | Brain+ A/S: Brain+ announces outcome of unit rights issue | 87 | GlobeNewswire (Europe) | Copenhagen, Denmark, 2 April 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA... ► Artikel lesen | |
26.03. | BRAIN+ A/S: Brain+ A/S informs of last day to subscribe in its ongoing rights issue of units | 1 | Cision News | ||
25.03. | BRAIN+ A/S: Brain+ to close first UK Care Home partnership contract with Southcare Homes Group | 1 | Cision News | ||
19.03. | Brain+ A/S: Brain+ expands its UK sales pipeline to €+500,000 in revenue and reveals Key Performance Indicators | 112 | GlobeNewswire (Europe) | Copenhagen, Denmark, 19 March 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or "the Company") today reports continued strong momentum in its sales pipeline, now exceeding €500... ► Artikel lesen | |
17.03. | BRAIN+ A/S: The subscription period in Brain+' rights issue of units begins today | 1 | Cision News | ||
11.03. | BRAIN+ A/S: UK care sector expert, Vishal Shah joins Brain+ as Advisor and Board Observer | 1 | Cision News | ||
10.03. | BRAIN+ A/S: The benefits of Ayla - your CST Assistant featured in CareTech, the healthtech media for Danish healthcare professionals | 1 | Cision News | ||
06.03. | Brain+ A/S: Brain+ resolves to carry out its earlier announced unit rights issue of up to approximately DKK 16 million | 161 | GlobeNewswire (Europe) | Copenhagen, Denmark, 6 March 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA... ► Artikel lesen | |
24.02. | Brain+ A/S - reduction of share capital by reducing face value per share | 138 | GlobeNewswire | The nominal share capital of Brain+ A/S will be reduced as of 26 February 2025 by reducing the face value of the company's shares from DKK 0.08 to DKK 0.01.
Name:
Brain+
ISIN:
DK0061670205
Short... ► Artikel lesen | |
12.02. | Brain+ A/S: Brain+ A/S - Minutes of Extraordinary General Meeting | 122 | GlobeNewswire (Europe) | Copenhagen, Denmark, 12 February 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Today at 08:00 CEST, an Extraordinary General Meeting was held in Brain+ A/S ("Brain+" or "the Company"). A total of... ► Artikel lesen | |
30.01. | BRAIN+ A/S: Invitation to Investor Webinar to update on sales outlook, restructuring and secured funding | 4 | Cision News |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
ATRICURE | 34,920 | 0,00 % | AtriCure Reports Fourth Quarter 2024 and Full Year 2024 Financial Results | MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and... ► Artikel lesen | |
GERRESHEIMER | 47,420 | -0,75 % | Gerresheimer: Gerüchte und neue Expertenstimmen | Gerresheimer-Aktien haben in dieser Woche massiv von Spekulationen um ein bevorstehendes Übernahmeangebot profitiert. Warburg Pincus und KPS sollen laut Bloomberg bereit sein, 70 Euro je Gerresheimer... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 46,490 | +0,82 % | BERENBERG stuft Siemens Healthineers auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für Siemens Healthineers mit einem Kursziel von 57,80 Euro auf "Buy" belassen. Der Tenor auf der Berenberg-MedTech-Investorenkonferenz... ► Artikel lesen | |
ADAPTHEALTH | 8,860 | -0,11 % | AdaptHealth Corp. - 10-Q, Quarterly Report | ||
FRESENIUS | 44,100 | +0,55 % | Erfolge für Nordex und Fresenius | Der Gesundheitskonzern FRESENIUS baut schon länger sein Geschäft mit Nachahmer-Medikamenten von biotechnologisch hergestellten Arzneimitteln (Biosimilars) aus. Der Ausschuss für Humanarzneimittel der... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 50,22 | +0,80 % | PRESSESPIEGEL/Unternehmen: MEYER WERFT, FMC, BRAINLAB/IPO | DJ PRESSESPIEGEL/Unternehmen
Die wirtschaftsrelevanten Themen aus den Medien, zusammengestellt von Dow Jones Newswires.
MEYER WERFT - Die vom Bund und dem Land Niedersachsen gerettete Meyer... ► Artikel lesen | |
GENEDX | 72,36 | 0,00 % | Sema4.ai raises $25M in funding for its AI agent platform | ||
ECKERT & ZIEGLER | 66,70 | +1,83 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler veranstaltet drittes Boston Radionuclide Theranostics Forum | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Sonstiges
Eckert & Ziegler veranstaltet drittes Boston Radionuclide Theranostics Forum
30.05.2025 / 10:00 CET/CEST
Für... ► Artikel lesen | |
CARL ZEISS MEDITEC | 58,75 | +1,82 % | BERENBERG stuft CARL ZEISS MEDITEC AG auf 'Hold' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für Carl Zeiss Meditec mit einem Kursziel von 65 Euro auf "Hold" belassen. Der Tenor auf der Berenberg-MedTech-Investorenkonferenz... ► Artikel lesen | |
HIMS & HERS HEALTH | 47,390 | +0,85 % | US-Telemedizin-Anbieter: Hims & Hers expandiert nach Europa: Zava bringt Millionen neue Nutzer! | © Foto: SOPA Images - Sipa USAHims & Hers übernimmt die europäische Telemedizin-Plattform Zava und wächst dadurch um 1,3 Millionen Nutzer. Die Aktie legt daraufhin im vorbörslichen Handel an der Nasdaq... ► Artikel lesen | |
NEUROPACE | 13,170 | 0,00 % | NeuroPace secures $75M credit facility with MidCap Financial | ||
BETA BIONICS | 19,460 | 0,00 % | Wolfe Research Initiates Coverage of Beta Bionics (BBNX) Stock with Outperform Rating | ||
UNITEDHEALTH | 264,55 | +0,49 % | Ihre wichtigsten Termine: Alle Analysten-Augen auf: UnitedHealth, Flatexdegiro und Friedrich Vorwerk! | Gut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine 10:00 Uhr, Deutschland: Friedrich... ► Artikel lesen | |
M1 KLINIKEN | 15,400 | +5,19 % | EQS-News: M1 Kliniken AG: Starkes Q1 2025 mit EBIT-Wachstum von 29 % und Ergebnis je Aktie von 0,31 EUR | EQS-News: M1 Kliniken AG
/ Schlagwort(e): Quartalsergebnis/Quartals-/Zwischenmitteilung
M1 Kliniken AG: Starkes Q1 2025 mit EBIT-Wachstum von 29 % und Ergebnis je Aktie von 0... ► Artikel lesen | |
PRIVIA HEALTH GROUP | 23,010 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2025 Financial Results | Strong First Quarter Performance and Operating ExecutionEnters the State of ArizonaFull-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged... ► Artikel lesen |